Product Description
The Acute Care CK-MB assay is an in vitro diagnostic test for the measurement of the MB iso-enzyme of creatine kinase in heparinized whole blood/plasma. CK-MB measurements can be used as an aid in diagnosing acute myocardial infarction.
| Brand | Siemens |
| Sample Type | Whole Blood |
| Pack Size | 100T |
| CAT No. | CCKMB |
Comprehensive Cardiac Diagnostic SolutionThe Stratus CS Acute Care CKMB TestPak offers a streamlined approach for cardiac biomarker evaluation. Its reagent-based technology ensures clinicians can perform quick, accurate testing at the point of care. Being portable, it seamlessly integrates into hospital labs and acute care environments, removing the need for permanent installation. Healthcare providers across India benefit from this advanced diagnostic equipment, capable of supporting rapid intervention and improved patient outcomes.
Accessible and Reliable for Hospital and Laboratory UseDesigned for both hospitals and clinical laboratories, the Stratus CS CKMB TestPak enhances diagnostic efficiency. Its portability allows clinicians to transport and use the reagent kit where needed, making it a practical tool for busy acute care settings. Supplied through a wide dealer and distributor network in India, its accessibility ensures that diagnostic quality and patient care standards are upheld in a wide range of medical institutions.
FAQ's of Stratus CS Acute Care CKMB TestPak:
Q: How does the Stratus CS Acute Care CKMB TestPak function in a hospital or laboratory setting?
A: The Stratus CS CKMB TestPak utilizes reagent technology to offer rapid testing for cardiac markers. It is portable, allowing healthcare professionals to perform diagnostics directly at the point of care, improving response times during critical cardiac events.
Q: What is the primary benefit of using this reagent kit in acute care environments?
A: The main benefit is its ability to deliver fast and reliable cardiac test results, aiding clinicians in making timely decisions for patients experiencing suspected heart conditions. Its portability further enhances its usability in urgent care scenarios.
Q: When should the Stratus CS Acute Care CKMB TestPak be used?
A: This test pack is most appropriate in emergencies or acute care settings where rapid cardiac biomarker assessment is vital, such as during episodes of chest pain or suspected myocardial infarction.
Q: Where is this equipment typically utilized within a healthcare facility?
A: The TestPak is primarily used in hospital emergency departments and clinical laboratories but can also be deployed in other settings that require portable, immediate cardiac testing capabilities.
Q: What is the process for conducting a test with this reagent?
A: To perform a test, a technician uses the portable Stratus CS system with the CKMB TestPak reagent. The reagent reacts with the patient's sample, and the analyzer provides quick quantitative results for cardiac biomarker levels.
Q: How does portable usage benefit hospital and lab operations?
A: Portability enables the TestPak to be moved easily across departments, reducing the need for patient transportation and allowing prompt diagnosis, which can positively impact patient care and workflow efficiency.